Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

The study’s primary endpoint, amputation-free survival after six months, was seen in 66.1% of CLTI patients who underwent transcatheter arterialization.

The recall, announced by the FDA, includes multiple lots of dabigatran etexilate capsules.

Using the World Health Organization’s model for analyzing gender-related healthcare needs, the authors of a new analysis aimed to explore disparities in PAD outcomes.

After its initial release was limited to certain customers, the new-look catheter is now available in four different sizes throughout the United States.

For patients who were hospitalized, but not yet in the ICU, those randomly assigned a higher-dose of anticoagulants had lower 30-day mortality risk than those on a lower dose. 

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said.